SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Value Investing -- Ignore unavailable to you. Want to Upgrade?


To: Paul Senior who wrote (44120)8/28/2011 3:18:11 PM
From: Madharry  Respond to of 78715
 
just a brief update on aab.to- they have a concentrated investment in sullidan sue.to which is very active in peru. peru has recently been beset by political issues but it sounds like the mining industry is close to agreement on new royalty rates which will restore some stability to that country in dealing with the miners. It sounds to me like aab management is confident that the stock is way undervalued or they would not continue to hold so much of their capital close to $28mm out of $117MM in one company. I hope they are right.

I find it interesting that Barrons which has never been bullish on gold or gold mining stocks, has produced 2 or three negative articles about gold in this weeks issue. I have no idea what will happen with gold over the next year or so but I dont see why people would sell except in response to the commodity xchanges raising their cash requirements for future positions. just looks like another boon for insiders to capitalize on non public info.
however it seems to me that having a another commodity market in china will still lesson the impact of that.
I guess the popularity of the gld etf comes at the expense of investments in gold miners, which to me seem way undervalued relative to gold itself.




To: Paul Senior who wrote (44120)8/28/2011 11:17:26 PM
From: Mr.Gogo2 Recommendations  Read Replies (1) | Respond to of 78715
 
This is the new piece in Bloomberg about the doctor.

bloomberg.com